- Home
- LH vs PODD Comparison
LH vs PODD Comparison
Compare LH & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LH | PODD |
|---|---|---|
| Founded | 1971 | 2000 |
| Country | United States | United States |
| Employees | 70000 | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9B | 17.0B |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | LH | PODD |
|---|---|---|
| Price | $269.73 | $237.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 20 |
| Target Price | $307.55 | ★ $358.00 |
| AVG Volume (30 Days) | 666.2K | ★ 1.0M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 18.33 | N/A |
| EPS | ★ 10.46 | 3.48 |
| Revenue | ★ $13,951,700,000.00 | $2,708,100,000.00 |
| Revenue This Year | $8.36 | $24.33 |
| Revenue Next Year | $4.73 | $19.33 |
| P/E Ratio | ★ $26.38 | $69.44 |
| Revenue Growth | 7.25 | ★ 30.73 |
| 52 Week Low | $209.38 | $230.08 |
| 52 Week High | $293.72 | $354.88 |
Technical Indicators
Market Signals| Indicator | LH | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 41.38 | 36.55 |
| Support Level | $258.40 | N/A |
| Resistance Level | $281.62 | $299.75 |
| Average True Range (ATR) | 6.84 | 8.38 |
| MACD | -2.00 | 0.50 |
| Stochastic Oscillator | 30.82 | 10.26 |
Price Performance
Historical ComparisonAbout LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.